Pasithea Therapeutics Corp. (KTTAW) Net Margin (2022)

Pasithea Therapeutics has disclosed Net Margin across 1 years of filings, most recently posting 3545.6% for Q4 2022.

• In Q4 2022, Net Margin changed N/A year-over-year to 3545.6%; the TTM figure through Dec 2022 stood at 3648.59% (changed N/A YoY), while the FY2022 annual figure was 3322.14%, up 1110836.0% from the prior year.
• Net Margin came in at 3545.6% for Q4 2022 at Pasithea Therapeutics, down from 1917.15% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 1917.15% in Q3 2022 to a low of 23024.29% in Q2 2022.